Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
|
29295717 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
|
29335545 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
|
28319090 |
2017 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.
|
23248098 |
2013 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice.
|
22581815 |
2012 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
|
22610119 |
2012 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Resveratrol and prostate cancer: promising role for microRNAs.
|
21714127 |
2011 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells.
|
21456062 |
2011 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
|
20729295 |
2010 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
|
19396168 |
2009 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
|
19081794 |
2008 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Integrative molecular concept modeling of prostate cancer progression.
|
17173048 |
2007 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.
|
16421604 |
2006 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
|
9371490 |
1997 |